Brief: Theravance Biopharma Q4 Operating Income USD -9.2 Million
26/02/2025 21:05
Feb 26 (Reuters) - Theravance Biopharma Q4 adjusted net income USD -2.472 million. Q4 net income USD -15.528 million
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions